# A Translational Study of Single Agent Olaparib in the Treatment of Advanced Oesophagogastric Cancer

> **NCT03829345** · PHASE2 · UNKNOWN · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 54 (estimated)

## Conditions studied

- Oesophageal Cancer
- Gastro-Oesophageal Junction Cancer
- Gastric Cancer

## Interventions

- **DRUG:** Olaparib

## Key facts

- **NCT ID:** NCT03829345
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-02
- **Primary completion:** 2021-02-14
- **Final completion:** 2022-02-14
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2019-07-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03829345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03829345, "A Translational Study of Single Agent Olaparib in the Treatment of Advanced Oesophagogastric Cancer". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT03829345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*